Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering ...

Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...

H ave you noticed people everywhere wearing continuous glucose monitors (CGM)? On the subway, at the gym, in the grocery ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System. This system is designed for Type 1 and Type 2 diabetics 18 and older and will be the first ...

Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

(MENAFN- GlobeNewsWire - Nasdaq) The Continuous Glucose Monitoring market is Growing at a CAGR of 7.80%, Driven by the Increasing Prevalence of Prediabetes and a Rising Demand for Monitoring ...

Implementation of continuous glucose monitoring (CGM ... The researchers also administered a System Usability Scale questionnaire to nurses who engaged with the CGM policy, whereas patients ...